Paul Wong is a trusted antitrust and competition and healthcare and life sciences economist. His expertise spans antitrust, industrial organization, healthcare, and applied microeconomics and econometrics. Dr. Wong has a strong track record, and he brings extensive experience across matters in state and federal courts, in private arbitrations, and before state and federal antitrust enforcement and regulatory agencies.
Dr. Wong has significant expertise in antitrust and competition and has authored more than 10 expert reports in antitrust matters involving US Sherman Act and Clayton Act (and equivalent state law) claims. He has testified multiple times at a live trial or hearing, including in antitrust trials and hearings in US district court. Among Dr. Wong’s notable antitrust litigation experience, he has worked on monopolization cases in the life sciences industry (Tevra v. Bayer), hospital industry (US v. Atrium), and IT industry (FTC v. Surescripts; In Re Surescripts), and he has worked on a wide variety of other antitrust issues, including exclusive dealing, bundling and tying, labor restraints, vertical merger and contracting restraints, predatory pricing, and fraud. In addition, Dr. Wong has done extensive work in the mergers and acquisitions space, including testimony in US district court for the GTCR/Surmodics merger challenged by the FTC. Beyond that case, Dr. Wong has worked on many mergers and joint ventures, including work on more than 100 transactions, multiple HSR Second Requests, multiple merger litigations in US district and state courts, and numerous transactions in a variety of industries, such as agriculture, technology, and insurance.
In the healthcare and life sciences space, in addition to work that sits at the intersection of antitrust and healthcare, Dr. Wong has worked on a variety of matters relating to hospitals, physicians, and health insurance. Of note, Dr. Wong has provided analysis and testimony on commercial damages for multiple cases involving “usual, customary, and reasonable” rates and other reimbursement disputes, and he has testified before a state legislature concerning healthcare policy issues.
Dr. Wong taught economics at the University of California Riverside’s Anderson Graduate School of Management, and he has conducted academic research on a variety of antitrust and healthcare issues, including publishing articles in journals such as Population Health Management, Loyola University Chicago Law Journal, Antitrust Chronicle, and Competition. Dr. Wong regularly presents to academic and professional audiences, and he has given seminars to a number of well-known organizations, such as the US Department of Justice, American Society of Health Economists, American Health Lawyers Association, and American Bar Association.